Literature DB >> 33478949

Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells.

Anthony Kusnadi1, Ciro Ramírez-Suástegui1, Vicente Fajardo1, Serena J Chee2, Benjamin J Meckiff1, Hayley Simon1, Emanuela Pelosi3, Grégory Seumois1, Ferhat Ay1, Pandurangan Vijayanand4,5,6, Christian H Ottensmeier4,5.   

Abstract

The molecular properties of CD8+ T cells that respond to SARS-CoV-2 infection are not fully known. Here, we report on the single-cell transcriptomes of >80,000 virus-reactive CD8+ T cells, obtained using a modified Antigen-Reactive T cell Enrichment (ARTE) assay, from 39 COVID-19 patients and 10 healthy subjects. COVID-19 patients segregated into two groups based on whether the dominant CD8+ T cell response to SARS-CoV-2 was 'exhausted' or not. SARS-CoV-2-reactive cells in the exhausted subset were increased in frequency and displayed lesser cytotoxicity and inflammatory features in COVID-19 patients with mild compared to severe illness. In contrast, SARS-CoV-2-reactive cells in the dominant non-exhausted subset from patients with severe disease showed enrichment of transcripts linked to co-stimulation, pro-survival NF-κB signaling, and anti-apoptotic pathways, suggesting the generation of robust CD8+ T cell memory responses in patients with severe COVID-19 illness. CD8+ T cells reactive to influenza and respiratory syncytial virus from healthy subjects displayed polyfunctional features and enhanced glycolysis. Cells with such features were largely absent in SARS-CoV-2-reactive cells from both COVID-19 patients and healthy controls non-exposed to SARS-CoV-2. Overall, our single-cell analysis revealed substantial diversity in the nature of CD8+ T cells responding to SARS-CoV-2.
Copyright © 2021, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33478949     DOI: 10.1126/sciimmunol.abe4782

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  60 in total

Review 1.  Metabolic adaptation of lymphocytes in immunity and disease.

Authors:  Nicole M Chapman; Hongbo Chi
Journal:  Immunity       Date:  2022-01-11       Impact factor: 31.745

Review 2.  'Stem-like' precursors are the fount to sustain persistent CD8+ T cell responses.

Authors:  Dietmar Zehn; Robert Thimme; Enrico Lugli; Gustavo Pereira de Almeida; Annette Oxenius
Journal:  Nat Immunol       Date:  2022-05-27       Impact factor: 31.250

3.  Resolving SARS-CoV-2 CD4+ T cell specificity via reverse epitope discovery.

Authors:  Mikhail V Pogorelyy; Elisa Rosati; Anastasia A Minervina; Robert C Mettelman; Alexander Scheffold; Andre Franke; Petra Bacher; Paul G Thomas
Journal:  Cell Rep Med       Date:  2022-07-01

4.  SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients.

Authors:  Ditte Stampe Hersby; Tripti Tamhane; Sunil Kumar Saini; Helle Rus Povlsen; Susana Patricia Amaya Hernandez; Morten Nielsen; Anne Ortved Gang; Sine Reker Hadrup
Journal:  Sci Immunol       Date:  2021-04-14

5.  SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses.

Authors:  Benedikt Agerer; Maximilian Koblischke; Venugopal Gudipati; Luis Fernando Montaño-Gutierrez; Mark Smyth; Alexandra Popa; Jakob-Wendelin Genger; Lukas Endler; David M Florian; Vanessa Mühlgrabner; Marianne Graninger; Stephan W Aberle; Anna-Maria Husa; Lisa Ellen Shaw; Alexander Lercher; Pia Gattinger; Ricard Torralba-Gombau; Doris Trapin; Thomas Penz; Daniele Barreca; Ingrid Fae; Sabine Wenda; Marianna Traugott; Gernot Walder; Winfried F Pickl; Volker Thiel; Franz Allerberger; Hannes Stockinger; Elisabeth Puchhammer-Stöckl; Wolfgang Weninger; Gottfried Fischer; Wolfgang Hoepler; Erich Pawelka; Alexander Zoufaly; Rudolf Valenta; Christoph Bock; Wolfgang Paster; René Geyeregger; Matthias Farlik; Florian Halbritter; Johannes B Huppa; Judith H Aberle; Andreas Bergthaler
Journal:  Sci Immunol       Date:  2021-03-04

Review 6.  Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity.

Authors:  Jenna L Collier; Sarah A Weiss; Kristen E Pauken; Debattama R Sen; Arlene H Sharpe
Journal:  Nat Immunol       Date:  2021-06-17       Impact factor: 31.250

7.  SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of the immune cells.

Authors:  Yogesh Singh; Christoph Trautwein; Rolf Fendel; Naomi Krickeberg; Georgy Berezhnoy; Rosi Bissinger; Stephan Ossowski; Madhuri S Salker; Nicolas Casadei; Olaf Riess
Journal:  Heliyon       Date:  2021-05-28

8.  Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity.

Authors:  Hengsheng Fang; Adam D Wegman; Kianna Ripich; Heather Friberg; Jeffrey R Currier; Stephen J Thomas; Timothy P Endy; Adam T Waickman
Journal:  Viruses       Date:  2021-05-15       Impact factor: 5.048

9.  Deep learning identifies antigenic determinants of severe SARS-CoV-2 infection within T-cell repertoires.

Authors:  John-William Sidhom; Alexander S Baras
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

10.  SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8 T cells.

Authors:  Anastasia A Minervina; Mikhail V Pogorelyy; Allison M Kirk; Jeremy Chase Crawford; E Kaitlynn Allen; Ching-Heng Chou; Robert C Mettelman; Kim J Allison; Chun-Yang Lin; David C Brice; Xun Zhu; Kasi Vegesana; Gang Wu; Sanchit Trivedi; Pratibha Kottapalli; Daniel Darnell; Suzanne McNeely; Scott R Olsen; Stacey Schultz-Cherry; Jeremie H Estepp; Maureen A McGargill; Joshua Wolf; Paul G Thomas
Journal:  medRxiv       Date:  2022-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.